Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerNature Mental Health · 2024-10-06Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-06-30The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersPsychedelic Medicine · 2023-08-29Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Unknown journal · 2023-07-22Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-08Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-08Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant useJournal of Psychopharmacology · 2023-06-07Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.Unknown journal · 2023-05-03Psychedelic-Assisted Therapy for People with Eating Disorders.Current psychiatry reports · 2022-11-30Serotonergic antidepressant use is associated with weaker psilocybin effectsPsyArXiv · 2022-10-27Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PLoS ONE · 2022-08-23Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Unknown journal · 2022-08-16Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-07-01Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and MetamemorybioRxiv · 2022-05-23Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain · 2022-03-31Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivitybioRxiv · 2022-03-01Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in Neuroergonomics · 2022-01-19The Potential of Psychedelics for End of Life and Palliative Care.Current topics in behavioral neurosciences · 2021-12-31Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.The international journal of neuropsychopharmacology · 2021-08-19Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.Unknown journal · 2021-04-30Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reportsPsyArXiv · 2021-02-23Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of Psychopharmacology · 2021-02-19Trends in the Top-Cited Articles on Classic Psychedelics.Journal of Psychoactive Drugs · 2021-02-02Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphanPsychopharmacology · 2020-06-04Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionNeuroImage · 2020-05-22Emotions and brain function are altered up to one month after a single high dose of psilocybinScientific Reports · 2020-02-09Cessation and reduction in alcohol consumption and misuse after psychedelic use.Unknown journal · 2019-05-13Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTPLoS ONE · 2019-04-22Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in Psychology · 2018-12-05Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Unknown journal · 2018-12-03Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-07-29Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of Psychopharmacology · 2018-06-24The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Unknown journal · 2018-06-04T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.Unknown journal · 2017-12-31Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Psychopharmacology · 2017-11-06Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in Psychology · 2017-07-24Potential Therapeutic Effects of Psilocybin.Unknown journal · 2017-06-30Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and Individual Differences · 2017-06-06Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settingsDrug and Alcohol Dependence · 2017-01-20Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-20An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of Psychopharmacology · 2017-01-17Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of Psychopharmacology · 2016-11-30The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of Psychopharmacology · 2016-11-16Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Long-term follow-up of psilocybin-facilitated smoking cessation.The American Journal of Drug and Alcohol Abuse · 2016-07-20Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The International Journal of Neuropsychopharmacology · 2016-07-04Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accountsDrug and Alcohol Dependence · 2015-10-31Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-10-31Comparative phenomenology of psilocybin experiences in research and non-research settingsDrug and Alcohol Dependence · 2015-10-30Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Unknown journal · 2015-10-05Psilocybin, psychological distress, and suicidality.Unknown journal · 2015-08-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.Journal of Psychopharmacology · 2014-09-10Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-06Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot studyDrug and Alcohol Dependence · 2014-06-06Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current Drug Abuse Reviews · 2013-12-31Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the Scientific Study of Religion · 2012-11-30High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Unknown journal · 2012-04-12Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and Alcohol Dependence · 2011-11-28Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of Psychopharmacology · 2011-09-27Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-06-14Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of Psychopharmacology · 2008-06-30Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.Psychopharmacology · 2006-07-06